Literature DB >> 17086201

Thymic selection threshold defined by compartmentalization of Ras/MAPK signalling.

Mark A Daniels1, Emma Teixeiro, Jason Gill, Barbara Hausmann, Dominique Roubaty, Kaisa Holmberg, Guy Werlen, Georg A Holländer, Nicholas R J Gascoigne, Ed Palmer.   

Abstract

A healthy individual can mount an immune response to exogenous pathogens while avoiding an autoimmune attack on normal tissues. The ability to distinguish between self and non-self is called 'immunological tolerance' and, for T lymphocytes, involves the generation of a diverse pool of functional T cells through positive selection and the removal of overtly self-reactive thymocytes by negative selection during T-cell ontogeny. To elucidate how thymocytes arrive at these cell fate decisions, here we have identified ligands that define an extremely narrow gap spanning the threshold that distinguishes positive from negative selection. We show that, at the selection threshold, a small increase in ligand affinity for the T-cell antigen receptor leads to a marked change in the activation and subcellular localization of Ras and mitogen-activated protein kinase (MAPK) signalling intermediates and the induction of negative selection. The ability to compartmentalize signalling molecules differentially in the cell endows the thymocyte with the ability to convert a small change in analogue input (affinity) into a digital output (positive versus negative selection) and provides the basis for establishing central tolerance.

Mesh:

Substances:

Year:  2006        PMID: 17086201     DOI: 10.1038/nature05269

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  297 in total

1.  T-cell tolerance: central and peripheral.

Authors:  Yan Xing; Kristin A Hogquist
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-06-01       Impact factor: 10.005

Review 2.  Tenuous paths in unexplored territory: From T cell receptor signaling to effector gene expression during thymocyte selection.

Authors:  Lie Wang; Yumei Xiong; Rémy Bosselut
Journal:  Semin Immunol       Date:  2010-10       Impact factor: 11.130

Review 3.  TCR signaling requirements for activating T cells and for generating memory.

Authors:  Dietmar Zehn; Carolyn King; Michael J Bevan; Ed Palmer
Journal:  Cell Mol Life Sci       Date:  2012-04-19       Impact factor: 9.261

Review 4.  Historical overview of immunological tolerance.

Authors:  Ronald H Schwartz
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

5.  Integrating multiple signals into cell decisions by networks of protein modification cycles.

Authors:  Luca Cerone; Javier Muñoz-Garcia; Zoltán Neufeld
Journal:  Biophys J       Date:  2011-10-05       Impact factor: 4.033

6.  Positive and negative signaling through SLAM receptors regulate synapse organization and thresholds of cytolysis.

Authors:  Fang Zhao; Jennifer L Cannons; Mala Dutta; Gillian M Griffiths; Pamela L Schwartzberg
Journal:  Immunity       Date:  2012-06-07       Impact factor: 31.745

Review 7.  Tolerance: an overview and perspectives.

Authors:  Herman Waldmann
Journal:  Nat Rev Nephrol       Date:  2010-08-17       Impact factor: 28.314

8.  The death effector domain protein PEA-15 negatively regulates T-cell receptor signaling.

Authors:  Sandra Pastorino; Hemamalini Renganathan; Maisel J Caliva; Erin L Filbert; John Opoku-Ansah; Florian J Sulzmaier; Joanna E Gawecka; Guy Werlen; Andrey S Shaw; Joe W Ramos
Journal:  FASEB J       Date:  2010-03-30       Impact factor: 5.191

Review 9.  Decision checkpoints in the thymus.

Authors:  Andrea C Carpenter; Rémy Bosselut
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

10.  The SH3 domain of Lck modulates T-cell receptor-dependent activation of extracellular signal-regulated kinase through activation of Raf-1.

Authors:  Manqing Li; Su Sien Ong; Bartek Rajwa; Vivian T Thieu; Robert L Geahlen; Marietta L Harrison
Journal:  Mol Cell Biol       Date:  2007-11-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.